8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Mar 3, 2026 · 4mo ago · Accession 0001104659-26-022539
Plain English
Passage Bio, Inc. reported its financial results for the year ended December 31, 2025, and provided an update on its clinical programs. The company also updated its corporate presentation.
Filing details
- Company
- Passage BIO, Inc.
- Ticker
- PASG
- CIK
- 1787297
- Form type
- 8-K
- Filing date
- Mar 3, 2026
- Report date
- Mar 3, 2026
- Document
- pasg-20260303x8k.htm
- Size
- 5.9 MB